Coluracetam, also known as BCI-540 or MKC-231, is a nootropic of the racetam class.
Coluracetam was originally studied in Japan in the mid-1990s for Alzheimer's treatment. These studies showed coluracetam's ability to repair memory and learning in mice with damaged nerve cells. However, none of the research on Alzheimer's has ever been published.
Coluracetam's second round of research, by Brain Cells Inc., on more than 100 people with major depression and anxiety, is reported to have shown benefits for major depressive disorder (MDD). However, these trials were never published either.
1) Memory and Learning
Coluracetam improved memory and learning in rats treated with a nerve toxin that damages the choline uptake system in the brain. This improvement surprisingly lasted beyond treatment. However, these benefits in learning and memory were not seen in rats who were not exposed to the nerve toxin.
Acetylcholine levels are often lower in those with Alzheimer's. By boosting acetylcholine in the hippocampus, coluracetam may improve some Alzheimer's symptoms, such as poor memory and learning.
In rats that were given the recreational drug (which inhibits ChAT, the enzyme that creates acetylcholine), coluracetam repaired the damage to the learning function by increasing ChAT.
2) Anxiet
In a rat study, dosing 21 days of coluracetam led to a 20% improvement in anxiety, which was greater than the 12% effect had in a single dose in the same study.
3) Schizophrenia
The enzyme that helps make acetylcholine (ChAT) is impaired in schizophrenia.
Coluracetam increased the activity of ChAT in rats with nerve cell damage. More research directly on people with schizophrenia is needed.
Kalitate handiko lantegi asko ditugu lankidetza sakonarekin, kalitate handiko produktuak eta prezio lehiakorrak eskain diezazkizuten. Eta ontziratu gabeko erosketetarako deskontuak ere eman ditzakegu. Eta merkantzien bidalketa-enpresa profesional askorekin lankidetzan aritzen gara, produktuak segurtasunez eta leunki entregatu ditzakegu zure eskuetara. Bidalketa-epea 3-20 egun ingurukoa da ordainketa baieztatu eta gero.
Produktuaren izena |
Coluracetam |
|
Item of Test |
Limits of Test |
Results of Test |
Itxura |
White Crystalline Powder |
White Crystalline Powder |
Assay (HPLC) |
≥ |
99.32% |
Particle |
100% pass 80 mesh |
Konforme |
Usaina |
Odorless |
Konforme |
Sulphated Ash |
<0.5% |
0.21% |
As |
<1.0ppm |
Konforme |
Pb |
<1.0ppm |
Konforme |
Cd |
<1.0ppm |
Konforme |
Hg |
<0.05ppm |
Konforme |
Loss on drying |
<3% |
1.05% |
Residue on igination |
≤%0,2 |
0.16% |
Plaka kopurua guztira |
<1000cfu/g |
Konforme |
Yeast & Mold |
<1000cfu/g |
Konforme |
E. Coli |
<100cfu/g |
Konforme |
S. Aureus |
Negatiboa |
Konforme |
Saimonella |
Negatiboa |
Konforme |
Pesticides |
Negatiboa |
Konforme |
Ondorioa |
Conform with specification |
|
Storage |
Store in 2-8°C, cool & dry place, Keep away from strong light and heat. |
Zer da produktu hau?
Coluracetam just might be the next new nootropic to dominate the market of brain supplements in the coming years. Like many of the other most popular nootropics, Coluracetam is a Racetam compound derived from Piracetam. Coluracetam has a lot of characteristics in common with other Racetams, but there are also some important distinctions.
Aplikazio
Formulations/Preparations:Tablets;Injection
Produktuen kategoriak